private:iecrowd
|
3014676
|
May 29th, 2019 12:00AM
|
ieCrowd
|
546
|
7.00
|
Open
|
Health, Wellness and Fitness
|
May 28th, 2019 09:43PM
|
May 28th, 2019 09:43PM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
Open
|
|
Open
|
1650 Spruce Street Suite 500
|
Riverside
|
CA
|
US
|
92507
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 17th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 16th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 15th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 14th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 13th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 12th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 11th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 10th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|
private:iecrowd
|
3014676
|
Feb 9th, 2018 12:00AM
|
ieCrowd
|
550
|
6.00
|
Open
|
Health, Wellness and Fitness
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
ieCrowd is a growing global community of impact investors with a mission to bring breakthrough health innovations to market that bring solutions to global challenges.
At ieCrowd, we secure full worldwide rights to commercialize health inventions. Once secured, we form a new subsidiary under ieCrowd for each innovation, and we assign and support in-house teams to focus on developing and bringing the innovations to market. This approach allows us to develop more than one innovation at a time, and diversifies shareholder risk amongst our subsidiaries.
Our experienced team has a track record of successfully bringing innovations to market, but we realized that together, as a crowd, we can have a larger impact on world health by commercializing more innovations and spreading our investors' risk among those innovations.
By partnering with leading research institutions and universities, we have access to a pipeline of innovations that usually don't make it out of the lab, but have the potential to improve health on a global scale. Our team of entrepreneurs, scientists, engineers, and impact investors identify and license the innovations that we believe will provide the highest financial return and will have the largest impact on global health.
To further mitigate investor risk, the technologies we license and commercialize must have received prior funding from public or private sources to finance the discovery’s research and development before we license the innovations and bring them to market.
Please follow us to hear about news, jobs and other opportunities.
|
|
|
|
|
|
|
|
|
|
ieCrowd
|
|
Pharmaceuticals & Biotechnology
|